Neuroprotective Potential of Berberine Against Doxorubicin-Induced Toxicity in Rat's Brain.
Ghadha I FouadKawkab A AhmedPublished in: Neurochemical research (2021)
Chemotherapy-associated neurotoxicity is one of the principal side-effects for doxorubicin (DOX)-treated cancer patients. Despite its poor-penetration across the blood-brain barrier (BBB), DOX is linked to the induction of oxidative stress and neuroinflammation. Berberine (BEB) is a natural polyphenolic alkaloid, which exhibits unique antioxidant activity and anti-inflammatory potential. The present study was performed to investigate the neuroprotective potential of BEB in a rodent model of DOX-induced neurotoxicity. Neurotoxicity was induced in rats via a single acute dose of DOX (20 mg/kg/week, i.p.). BEB was administered at 50 mg/kg/day orally for 10 days before and 4 days after DOX administration. Brain acetylcholinesterase (AChE) activities were evaluated. Oxidative stress was investigated via the colorimetric determination of lipid peroxides, glutathione reduced (GSH) contents and catalase (CAT) activities in the brain tissue. In addition, DOX-induced genotoxicity was evaluated using comet assay. DOX produced a significant elevation in AChE activities. Additionally, DOX provoked oxidative stress as evidenced from the significant elevation in lipid peroxidation along with depletion in GSH contents and CAT activities. Moreover, DOX resulted in neuroinflammation as indicated by the elevation of pro-inflammatory mediator glial fibrillary acid protein (GFAP), as well as, the pro-apoptotic nuclear factor kappa B (NF-κB) and caspase-3 in brain tissue. Co-treatment with BEB significantly counteracted DOX-induced oxidative stress, neuroinflammation and genotoxicity. Histopathological and immunohistochemical examination supported the biochemical results. BEB demonstrated neuroprotective potential through exerting cholinergic, anti-oxidative, genoprotective, anti-inflammatory, and anti-apoptotic activities. Our findings present BEB as a promising "pre-clinical" neuroprotective agent against DOX-induced neurotoxicity during anti-neoplastic therapy.
Keyphrases
- oxidative stress
- diabetic rats
- cerebral ischemia
- nuclear factor
- anti inflammatory
- high glucose
- drug induced
- blood brain barrier
- cell death
- dna damage
- toll like receptor
- white matter
- lipopolysaccharide induced
- induced apoptosis
- radiation therapy
- immune response
- squamous cell carcinoma
- drug delivery
- clinical trial
- inflammatory response
- multiple sclerosis
- signaling pathway
- acute respiratory distress syndrome
- intensive care unit
- cell proliferation
- amino acid
- endoplasmic reticulum stress
- locally advanced
- combination therapy
- mechanical ventilation
- risk assessment
- solid phase extraction
- double blind